Financials

  • Market Capitalization 355.58 M
  • Employee 35
  • Founded 1996
  • CEO N/A
  • Website www.fennecpharma.com
  • Headquarter British Columbia, Canada
  • FIGI BBG000DTH814
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-22.65
売上高対価格比率
4.93

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
3066
KYTX
Kyverna Therapeutics, Inc. - Common Stock
5.92 USD-4.67%-6.48%-18.34%-11.38%366.11 M USD
3068
RLMD
Relmada Therapeutics, Inc. - Common Stock
3.43 USD-2.28%+1.18%-24.28%+73.23%365.88 M USD
3097
CCCC
C4 Therapeutics, Inc. - Common Stock
2.87 USD-6.21%-1.37%-17.05%+36.67%353.08 M USD
3118
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
5.74 USD-2.88%-2.21%-6.06%+79.38%345.00 M USD